nsc-172755 has been researched along with streptomycin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Anagonou, SY; Foundohou, J; Gninafon, M; Josse, R; Kinde-Gazard, D; Tawo, L | 1 |
| Aguiar, J; Debacker, M; Meyers, WM; Portaels, F; Steunou, C; Zinsou, C | 1 |
| Affolabi, D; Anagonou, S; Anyo, G; Faïhun, F; Kestens, L; Portaels, F; Rigouts, L; Sanoussi, N; Shamputa, IC | 1 |
| Barogui, YT; Brun, LV; Dossou, AD; Johnson, RC; Pluschke, G; Ruf, MT; Sopoh, GE | 1 |
| Agbo, IE; Amoussouhoui, AS; Aoulou, P; Boyer, M; Houezo, JG; Johnson, RC; Nichter, M; Sopoh, GE; Wadagni, AC | 1 |
| Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T | 1 |
1 trial(s) available for nsc-172755 and streptomycin
| Article | Year |
|---|---|
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult | 2020 |
6 other study(ies) available for nsc-172755 and streptomycin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Buruli ulcer recurrence, Benin.
Topics: Anti-Bacterial Agents; Benin; Endemic Diseases; Follow-Up Studies; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Recurrence; Rifampin; Skin Diseases, Bacterial; Streptomycin | 2005 |
Possible outbreak of streptomycin-resistant Mycobacterium tuberculosis Beijing in Benin.
Topics: Anti-Bacterial Agents; Benin; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genetic Predisposition to Disease; HIV Seropositivity; Humans; Male; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2009 |
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Biopsy; Buruli Ulcer; Child; Child, Preschool; Debridement; Drug Therapy; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Microscopy; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome; Young Adult | 2011 |
Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Community Health Services; Disease Management; Early Medical Intervention; Female; Health Impact Assessment; Health Plan Implementation; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin | 2018 |